These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15993508)

  • 1. Precipitation casting of drug-loaded microporous PCL matrices: incorporation of progesterone by co-dissolution.
    Chang HI; Williamson MR; Perrie Y; Coombes AG
    J Control Release; 2005 Sep; 106(3):263-72. PubMed ID: 15993508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gravity spun polycaprolactone fibres: controlling release of a hydrophilic macromolecule (ovalbumin) and a lipophilic drug (progesterone).
    Williamson MR; Chang HI; Coombes AG
    Biomaterials; 2004 Sep; 25(20):5053-60. PubMed ID: 15109868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous release of hydrophilic drugs from poly(epsilon-caprolactone) matrices.
    Rosenberg R; Devenney W; Siegel S; Dan N
    Mol Pharm; 2007; 4(6):943-8. PubMed ID: 17960890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone.
    Chang HI; Perrie Y; Coombes AGA
    J Control Release; 2006 Jan; 110(2):414-421. PubMed ID: 16325955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of polycaprolactone matrices for the intravaginal delivery of metronidazole in the treatment of bacterial vaginosis.
    Pathak M; Turner M; Palmer C; Coombes AG
    J Biomater Appl; 2014 Sep; 29(3):354-63. PubMed ID: 24682036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of the macroporosity of polycaprolactone-based biocomposites and release kinetics for drug delivery.
    Wang Y; Chang HI; Wertheim DF; Jones AS; Jackson C; Coombes AG
    Biomaterials; 2007 Nov; 28(31):4619-27. PubMed ID: 17659772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective antitumor activity of paclitaxel-loaded poly (epsilon-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model.
    Ma G; Yang J; Zhang L; Song C
    Anticancer Drugs; 2010 Mar; 21(3):261-9. PubMed ID: 20016371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled protein release from electrospun biodegradable fiber mesh composed of poly(epsilon-caprolactone) and poly(ethylene oxide).
    Kim TG; Lee DS; Park TG
    Int J Pharm; 2007 Jun; 338(1-2):276-83. PubMed ID: 17321084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents.
    Dang NT; Turner MS; Coombes AG
    J Biomater Appl; 2013 Jul; 28(1):74-83. PubMed ID: 22684517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery.
    Coombes AG; Rizzi SC; Williamson M; Barralet JE; Downes S; Wallace WA
    Biomaterials; 2004 Jan; 25(2):315-25. PubMed ID: 14585719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants.
    Li C; Cheng L; Zhang Y; Guo S; Wu W
    Int J Pharm; 2010 Feb; 386(1-2):23-9. PubMed ID: 19895876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
    Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
    J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers.
    Luong-Van E; Grøndahl L; Chua KN; Leong KW; Nurcombe V; Cool SM
    Biomaterials; 2006 Mar; 27(9):2042-50. PubMed ID: 16305806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs.
    Poletto FS; Jäger E; Ré MI; Guterres SS; Pohlmann AR
    Int J Pharm; 2007 Dec; 345(1-2):70-80. PubMed ID: 17604922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of bioactive macromolecules from microporous polymer matrices: Release and activity profiles of lysozyme, collagenase and catalase.
    Wang Y; Chang HI; Li X; Alpar O; Coombes AG
    Eur J Pharm Sci; 2009 Jun; 37(3-4):387-94. PubMed ID: 19491030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery.
    Park EK; Kim SY; Lee SB; Lee YM
    J Control Release; 2005 Dec; 109(1-3):158-68. PubMed ID: 16263189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of polycaprolactone matrices for vaginal delivery of the antiviral, tenofovir, in preventing heterosexual transmission of HIV.
    Dang NT; Sivakumaran H; Harrich D; Coombes AG
    J Pharm Sci; 2013 Oct; 102(10):3725-35. PubMed ID: 23904196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of drug release from biodegradable polymer blends.
    Lao LL; Venkatraman SS; Peppas NA
    Eur J Pharm Biopharm; 2008 Nov; 70(3):796-803. PubMed ID: 18577449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.